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Abstract Bacteria and fungi use a set of enzymes called
nonribosomal peptide synthetases to provide a wide range
of natural peptides displaying structural and biological
diversity. So, nonribosomal peptides (NRPs) are the basis
for some efficient drugs. While discovering new NRPs is
very desirable, the process of identifying their biological
activity to be used as drugs is a challenge. In this paper, we
present a novel peptide fingerprint based on monomer
composition (MCFP) of NRPs. MCFP is a novel method
for obtaining a representative description of NRP structures
from their monomer composition in fingerprint form.
Experiments with Norine NRPs database and MCFP show
high prediction accuracy ([93 %). Also a high recall rate
([82 %) is obtained when MCFP is used for screening
NRPs database. From this study it appears that our fin-
gerprint, built from monomer composition, allows an
effective screening and prediction of biological activities of
NRPs database.
Keywords Nonribosomal peptides  Target Prediction 
Similarity searching  Drug discovery
Introduction
For thousands years, natural products are an important
source of drugs [1]. They are produced by marine or ter-
restrial organisms (plants, vertebrates, invertebrates…) and
microorganisms (fungi, bacteria, algae). Many studies in
the literature discuss the importance of natural products in
drug discovery [2–5]. They are still important sources for
many drugs in the market (e.g. morphine, cocaine, peni-
cillin, taxols…) and are also good lead compounds suitable
for further modification during drug development. Intro-
ducing a new compound on the market is time consuming
and cost-intensive process [6, 7], in particular for natural
products, so that strategies allowing time saving are
welcomed.
The discovery of natural products requires specific steps
as they are synthesized by living organisms. For example,
scientists need to determine which organisms produce
interesting compounds and define the conditions of pro-
duction. The produced compounds have to be extracted
from cultured media or from natural environments. Finally,
chemical structures are determined. Those structures can,
finally, be mimicked leading to artificial compounds. To
reduce the time and cost of the specific steps, the optimal
process is to predict the compounds produced by an
organism directly from its genome sequence. This strategy
can be particularly performed with nonribosomal peptides.
Those peptides are synthesized by a ribosome-indepen-
dent cell machinery. This alternative pathway produces
peptides using large multi-enzymatic complexes called
nonribosomal synthetases (NRPSs) [8]. Those synthetases
are composed of proteins organized in modules, each one
being responsible for the incorporation of one specific
amino acid in the final peptide. A relationship between
specific signatures and a given incorporated amino acid
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have been determined from protein sequences of NRPSs
[9–12]. So, from a genome sequence, bioinformatics
analysis allows to extract genes coding for NRPSs, to
deduce their protein sequences and to predict the amino
acids incorporated in the produced peptide [13]. This pre-
dicted peptide can then be analyzed by bioinformatics tools
to infer its putative activity.
We have collected nonribosomal peptides in Norine
(http://bioinfo.lifl.fr/norine/) [14], the first and still unique
computational resource dedicated to nonribosomal peptides
(NRPs). Each peptide has a unique Norine identifier in the
form NOR followed by a number of 5 digits. The database
contains more than 1,100 nonribosomal peptides extracted
from scientific literature with manually curated annotations
such as biological activity, producing organisms or bib-
liographic references and, most importantly, their mono-
meric structure. We used the universal term monomer
instead of amino acid because the entities encountered into
those peptides do not only include the 21 proteogenic
amino acids, but also derivates or unusual ones; other
compounds such as carbohydrates or lipids can also be
incorporated. Norine currently references 526 different
monomers occurring in the listed peptides. The monomeric
structures are encoded by undirected labelled graphs, with
nodes representing monomers and edges corresponding to
chemical bonds between them. One monomer can display
more than two peptidic bonds, and non peptidic bonds are
also observed in NRPs leading to peptides with cycles
and/or branches. The database can be queried for peptide
search through their annotations as well as through their
monomeric structures. It also contains a section dedicated
to the monomers incorporated into the peptides stored in
Norine.
Due to the particular way of synthesis, nonribosomal
peptides are a valuable source of a wide range of structural
and biological activities, produced by microbial cells
(typically bacteria and fungi). The NRPs may represent
novel drugs for several pharmaceutical areas including
antibiotics (penicillin and cephalosporin the precursor of
which is ACV, NOR00006), antitumors (actinomycin D,
NOR00228), and immunosuppressive agents (cyclosporin
A, NOR00033). They can also be exploited in biotechno-
logical applications such as biosurfactants. Their various
and interesting biological activities almost comes from
their original mode of synthesis that offers huge flexibility
by including non proteogenic monomers and cycles and
branching.
As they are small and exploited in pharmacology and
biotechnology, nonribosomal peptides are usually repre-
sented by atomic structures and stored in chemical com-
pounds databases. Classical chemo-informatics tools are
applied to them as part of generalist chemical databases to
predict their activity or do some structure search or
comparison. Norine contains few links to structural con-
formation databases such as PDB (25 NRPs). However, the
length of this data set is too low to be exploited for NRP
comparison or activity prediction.
Due to the similar property principle, structurally similar
compounds are expected to exhibit similar properties and
similar biological activities. This principle is exploited for
in silico drug discovery. The chemical compounds are
virtually screened either by docking into the active site of
interest or by virtue of their similarity to a known active.
Many studies suggest that knowledge about a target
obtained from known bioactive ligand is as valuable as
knowledge of the target structures for identifying novel
bioactive scaffolds through virtual screening [15, 16].
But, NRPs exhibit specificities in comparison to typical
synthetic compounds (synthesis pathway, complex struc-
tures). So, published numerical representations for chemi-
cal compounds, such as fingerprints, may not be the
optimal choice to represent NPRs. Our monomeric
approach opens new ways to analyze them. As first
observations showing that some monomers are specific to a
given activity [17] were promising, we decided to further
investigate the relationship between the NRP monomer
structures and their activity.
In this paper a new fingerprint based on monomeric
composition of NRPs is introduced. Monomer composition
fingerprint (MCFP) is a new method for obtaining a rep-
resentative description of NRP structures from their
monomer composition in fingerprint form. In this work, we
present experiments that show the usefulness of monomer
composition fingerprint when used for similarity searching
and activity prediction of NRPs.
Materials and methods
Monomer composition fingerprint (MCFP)
MCFP is represented as an integer vector, in which each
element represents the presence (number of occurrences) or
absence (‘‘0’’ value) of a specific monomer. The process of
generating the MCFP for each peptide starts by extracting
the monomer compositions from Norine and then filling the
corresponding positions in the MCFP vector. We use the
526 monomers referenced in Norine as individual elements
(see Fig. 1). For example, the peptaibolin (NOR01028) is
composed of the monomers NAc-Leu (N-acetyl-leucine),
Aib (2-aminoisobutyric acid), Leu (leucine), Aib (2-Ami-
noisobutyric acid) and Pheol (phenylalaninol) and gener-
ates a fingerprint with three elements set to ‘‘1’’, one to ‘‘2’’
and the rest (522) set to ‘‘0’’. Four elements are ‘‘on’’ for
this peptide of length five because the monomer Aib is
repeated twice.
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Similarity search system
We use Tanimoto-based similarity search system (TAN).
This system is based on the Tanimoto coefficient that is a
well established method in similarity-based virtual
screening and was therefore used as reference. In particu-
lar, the continuous form of the Tanimoto coefficient was
used. If Ai and Bi represent the ith monomer occurrence in
the peptides A and B, respectively, the similarity score SA,B
















The advantage of this score is the direct use of monomer
occurrences in the equation and the neutrality of empty
elements. This equation has been widely used for chemical
similarity searching. However, a detailed study of fragment
weighting schemes has recently suggested that superior
screening performance is obtained if the square roots of the
element occurrence frequencies are used rather than the
unmodified frequencies [18–21]. We have hence carried
out experiments in which the raw monomer occurrences in
the TAN similarity measures are replaced by the square
roots of those occurrences. The TAN coefficient varies
between 0 (totally different monomer compositions) and 1
(identical monomer compositions).
Activity prediction system
We use in our experiments three machine learning algo-
rithms available in WEKA-Workbench [22, 23]. The naive
Bayesian classifier [24], the linear (LibLinear) classifier
[25], and the SMO classifier [26]. Details on these algo-
rithms can be found in their references. The machine
learning algorithms are used with their default settings in
the WEKA-Workbench.
Data sets
The data set for this study is taken from the Norine data-
base (version of April 2012), which contains 1122 peptides
with 11 distinct activities. We don’t consider the surfactant
activity as it is more a physico-chemical property (being a
lipopeptide or not) than a biological activity. The database
is first filtered so that, activity classes containing less than
20 peptides are removed. Then, peptides with same
monomer lists, even with different number of occurrences
(same elements ‘‘on’’ in the MCFP), within an activity
class are removed. Finally, we only consider the peptides
with only one known activity. A total of 605 peptides were
available for forming our test set, belonging to 5 different
activity classes.
(1) The antibiotics class (319 NRPs) includes different
NRPs categories, which are peptaibols (linear peptides
Fig. 1 MCFP generation
process
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produced by fungi), glycopeptides (vancomycin-like
with several cycles in their monomer structure),
lipopeptides, pure peptides and even chromopeptides.
It is to notice that, in Norine, 210 peptides share
antibiotic with other activities (antitumor, toxin, sur-
factant or immuno-modulator). Those 210 peptides are
included in the evaluation data set (see discussion
section).
(2) Toxins (157 NRPs) harbor different modes of action
to kill cells. They are pure peptides or lipopeptides. In
Norine, 103 NRPs that are toxins are also antibiotics,
antitumors or surfactants. They are also in the
evaluation data set.
(3) Siderophores (82 NRPs) chelate (bind) iron mole-
cules with specific monomers, including chromoph-
ores. They are mainly chromopeptides, but can also
be lipopeptides or pure peptides. Among the 82
siderophore peptides, 18 are also known as
surfactants.
(4) Antitumors (25 NRPs) operate with different modes
of action, being mainly pure peptides. In Norine, 71
NRPs that are antitumors are also antibiotics, toxins
or immuno-modulator. They are also in the evaluation
data set.
(5) Protease inhibitors (22 NRPs) are all pure peptides.
This class never crosses with other classes, as far as
we know.
Performance of machine learning algorithms depends on
the training data set (peptides with or without a given
activity). The negative set, peptides without the studied
activity, for any single activity class derives from the
positive sets, that are peptides having any other activity.
Validation
The similarity searching experiments were performed with
20 peptides selected randomly (as queries) from each
activity class. The recall results were averaged over each
such set of active peptides. The recall is the percentage of
active peptides retrieved in the top-1 % or the top-5 % of
the ranked list resulting from a similarity search.
For activity prediction experiments, 10-fold cross-vali-
dation was used to validate the results of different machine
learning algorithms. In this cross-validation, the data set is
split into 10 parts; one part is used for testing, the
remaining 9 parts for training. This is repeated 10 times, so
all the data have been used as test data once. Each activity
class is tested against all the others, grouped. As in the case
of many prediction methods, we used the F-measure as
quality criterion to quantify the performance of MCFP with
different classification algorithms. F-measure is defined as
the harmonic mean of precision and recall. The precision is
defined by prec = tp/(tp ? fp) and the recall (or sensitiv-
ity) is defined by rec = tp/(tp ? fn), where tp, fp and fn are
the number of true positives, false positives, and false
negatives, respectively. We also used accuracy (ac) and
area under the Receiver Operating Characteristic (ROC)
curve (AUC) measures to quantify the performance of
MCFP with different classification models. Accuracy is the
overall correctness of the model and is calculated as the
sum of correct classifications divided by the total number
of classifications ac = (tp ? tn)/(tp ? tn ? fp ? fn).
Further metrics of statistical performance analysis
involved the ROC curve, which has been used in various
fields (medicine, meteorology, etc.) [27] and also in drug
discovery field [28]. A ROC curve describes the tradeoff
between sensitivity and specificity, where the sensitivity is
defined as the ability of the model to avoid false negatives,
and the specificity relates to its ability to avoid false pos-
itives. The area under the ROC curve (AUC) is a measure
of the model performance: the closer to 1, the better is the
performance of the prediction.
Results
Similarity-based results
Details of the pairwise similarities among the activity
classes are given in Table 1. A rough guide to the diversity
of each of the chosen sets of NRPs is provided by matching
each peptide with every other in its activity class (intra-
class) or with all the 605 used in this study (inter-class),
calculating the Tanimoto coefficient applied to MCFP. The
class diversity is measured by computing the mean and the
number of comparisons having a coefficient greater than or
equal to 0.7 for these intra-class similarities. The histogram
of Fig. 2 gives an overview of the pairwise distances
obtained among intra- and inter-classes. The number of
pairwise comparisons with a high score is low for all the
classes, confirming a high diversity.




Pairwise TAN TAN recall
Mean % C0.7 Top 1 % Top 5 %
Antibiotics 319 0.09 3.69 88.33 81.50
Toxin 157 0.09 1.65 75.00 59.33
Siderophore 82 0.18 2.11 100.00 90.83
Antitumor 25 0.27 8.67 67.50 45.21
Protease inhibitors 22 0.26 9.52 80.83 56.90
All against all 605 0.05 1.21
Mean 82.33 66.75
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The results for the searches in the data set are shown in
Table 1. Each row corresponds to one activity class and
lists the recall for the top 1 and 5 % of a sorted ranking
when averaged over the ten searches for this activity class.
Results reported in Table 1 show that TAN system with
MCFP obtains overall average recall rates of 82 and 67 %
for top 1 and 5 %, respectively. It has the best performance
for siderophore, antibiotics, and protease inhibitors activity
classes while performing least well for antitumor and toxin.
We observe a diminution of the recall between top-1 % and
top-5 %.
Biological activity prediction results
Visual inspection of the precision, recall, F-measure and
accuracy rates in Table 2 enables one to make comparisons
between the effectiveness of using MCFP with various
prediction models. The MCFP with LibLinear approaches
produce the best performance across the five activity
classes, with SMO and NaiveB also performing well. In
only one class (antitumor activity), the performance of the
MCFP with different prediction models was low. In terms
of the overall correctness of the prediction, MCFP finger-
print with different prediction approaches produced high
accuracy rates, especially with LibLinear model ([93 %).
In this study we used the ROC curve to study the per-
formance of MCFP with different prediction models.
Table 2 shows that the AUC value is always close to 1
([0.93).
Discussion
The main aim of this study is to introduce the monomer
composition fingerprint as a useful representation for NRPs
and then identify the effectiveness of using such repre-
sentation in similarity-based and prediction of the activity
for those peptides displaying many different biological
activities. The best selection of descriptors/fingerprints is
based on their accuracy in predicting the property/activity
of a peptide from another peptide that is considered similar
to it, by using either a similarity method, or a clustering or
its k-nearest neighbors. For those descriptors, and for
predicting the activity class of peptides, the best descriptors
are those yielding the highest number of correct predictions
(peptides with similar activity class), taking into account
the total number of peptides having this activity in the
database used. To achieve this aim, the Tanimoto similarity
system (TAN, see Eq. 1) and three different machine
learning approaches (NaiveB, LibLinear, and SMO) have
been applied.
The TAN calculated on monomer composition finger-
print demonstrates good results for the recall computed on
the top-1 %, except for the toxin and antitumor classes.
The toxin class has only 14 % of specific monomers and
shares up to 81 % of its monomers with the antibiotic class
(see Table 4). So, they can match with antibiotics or other
peptides because of their common monomers. This is not
surprising as those activities are biologically closed and
can even be both harbored by a single peptide (72 peptides
of Norine are known to be antibiotics and toxins, we tested
them as an evaluation data set). This is even worse for
antitumors that have no specific monomers and share 96 %
of their monomers with antibiotics and toxins. Their TAN
recall is lower than the one of toxin. At the opposite,
protease inhibitors have also no specific monomers and
share 88 % of their monomers with antibiotics and toxins,
but show the third best recall of the set. This is certainly
Fig. 2 Histogram for pairwise similarity using Tanimoto coefficient
Table 2 Precision, recall, F-measure, accuracy and AUC rates for the prediction models
Activity class Naı¨ve Bayesian LibLinear SMO
Prec Rec F AUC Prec Rec F AUC Prec Rec F AUC
Antibiotics 0.971 0.737 0.838 0.961 0.950 0.962 0.956 0.953 0.947 0.953 0.950 0.942
Toxin 0.656 0.898 0.758 0.946 0.899 0.904 0.902 0.934 0.889 0.917 0.902 0.937
Siderophore 0.890 0.988 0.936 0.998 0.988 0.963 0.975 0.981 1 0.951 0.975 0.994
Antitumor 0.471 0.640 0.542 0.935 0.696 0.64 0.667 0.814 0.696 0.640 0.667 0.868
Protease inhibitors 0.870 0.909 0.889 0.996 0.952 0.909 0.930 0.954 0.952 0.909 0.930 0.975
Accuracy 81.49 93.22 92.89
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due to the fact that they are small peptides (3, 4, 5 or 7
monomers) in comparison to the other peptides (mean
number of monomers is around 10) and that their compo-
sition is specific of their activity. It is to notice that no
peptide of Norine share protease inhibitor activity with
another activity. Finally, antibiotics have the second best
recall (88 %, in top 1 %), but it is not so good (as sider-
ophore) because, as mentioned before, antibiotic class is
constituted by several sub-groups that differ in monomer
composition, structure and mode of action (they are pep-
taibols, glycopeptides, lipopeptides, pure peptides or
chromopeptides). But the number of NRPs in each sub-
class is sufficiently high to find similar peptides in top-1 %
and top-5 % lists. Generally, the recall results presented
here are highly interesting and promising. That is because
this data set comprises heterogeneous activity classes
which are normally considered as very challengeable in
similarity-based searching. We plan to study more deeply
the intra-class similarities to distinguish sub-classes among
the actual activity classes, if some can be designed.
The prediction accuracy rates obtained with the three
machine learning approaches are promising because they
are higher than 90 %. Again, and for the same reasons,
antitumor class gives lower rates. However, the mispre-
dicted cases in antitumor class (see Table 3) are not really
incorrect. This is because these cases are predicted as
antibiotic and toxin classes and as we mentioned above, in
Norine, NRPs that are antitumors can also be antibiotics
and toxins. This finding is also supported by the number of
common monomers between antitumor, antibiotic and
toxin classes (Table 4). We plan to study the data sets
within each class and across classes to improve the pre-
dictions. For example, isolated peptides can be removed
from the classes.
In order to assess the true predictivity of any model it is
necessary to have an independent data set (evaluation data
set) against which the model predictions can be compared.
The evaluation data sets are different from the training data
sets used to build the model. This approach makes it pos-
sible for users to judge the robustness and predictivity of
the model when making predictions. Therefore, we predict
the activity of 5 peptides that are not yet included in Norine
Table 3 Confusion matrix for different prediction models
Activity class Naı¨ve Bayesian LibLinear SMO
a b c d e a b c d e a b c d e
a 235 64 9 11 0 307 9 0 3 0 304 11 0 4 0
b 5 141 1 7 3 9 142 1 4 1 9 144 0 3 1
c 0 1 81 0 0 1 2 79 0 0 2 2 78 0 0
d 2 7 0 16 0 6 3 0 16 0 4 5 0 16 0
e 0 2 0 0 20 0 2 0 0 20 2 0 0 0 20
a antibiotics, b Toxin, c Siderophore, d Antitumor, e Protease inhibitors












Antibiotics 38 55 22 26 13
Toxin 81 14 24 20 39
Siderophore 74 55 26 32 13
Protease
inhibitors
96 96 36 0 29
Antitumor 88 88 25 50 0
You should read the table by row. For example, antibiotics share 55 % of their
monomers with toxins; antibiotics have 38 % of specific monomers. The sum
of the rows is not equal to 100 % because some monomers are shared between
several classes
The numbers in bold are the percentages of monomers specific of each activity






Coelichelin [29] Siderophore Siderophore D-Fo-OH-Orn, D-aThr, OH-Orn, D-Fo-OH-Orn
Hypomurocin A1 [30] Antibiotic Antibiotic Ac-Aib, Gln, Val, Val, Aib, Pro, Leu, Leu, Aib, Pro, Leuol
Orfamide A [31] Antibiotic Toxin C14:0-OH(3); Leu,D-Glu, D-aThr, D-aIle, Leu,D-Ser, Leu, Leu, D-Ser, Val
Pyoverdin PSEN [32] Siderophore Siderophore ChrP, D-Ala, Asn,Dab, OH-His, Gly, Gly, Ser, Thr, D-Ser, OH-cOrn
TVB I [33] Antibiotic Antibiotic Ac-Aib, Gly, Ala, Val, Aib, Gln, Aib, Ala, Aib, Ser, Leu, Aib,
Pro, Leu, Aib, Aib, Gln, Valol
The good predictions are in bold
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(see Table 5) and built an exhaustive evaluation set with
232 peptides that are in Norine but not in the initial data set
as they have at least two known activities. The data sets
and predictions obtained with LibLinear method are pre-
sented in Tables 5 and 6. The correct activity, described in
source papers, is predicted for 4 out of the 5 new peptides.
Orfamide A is an antibiotic predicted as toxin, but crosses
between antibiotic and toxin predictions are also observed
in our initial data set. The results obtained for the evalua-
tion set are promising as we predict correctly one of the
activities for 83 % among the 237 tested peptides. This rate
is similar to the one found with the cross-validation done
with the initial data set, even if the activities represented in
this set are challenging because they are the ones with the
higher rate of crossing (antibiotic, antitumor and toxin).
The prediction results for the evaluation data set clearly
show the usefulness and robustness of our approach.
To improve the results in both similarity search and
activity prediction, we will work on the fingerprints. On one
hand, determining clusters of monomers will reduce the
numbers of elements in the fingerprints and increase the
common elements between peptides. On the other hand,
adding of structure information such as monomer neigh-
borhood will increase the number of elements in the finger-
prints and improve the discrimination between two NRPs
with similar monomer compositions but different structures.
The results obtained show that monomer composition
fingerprint provides an interesting alternative to the widely
used atomic fingerprints for similarity-based searching and
biological activity prediction of nonribosomal peptides.
However, beside the good performance of MCFP, it is
efficient compared to any other representation approach,
since dealing with fingerprint calculation is faster and
conduct at minimal computational cost.
Conclusion
In this paper, we present a new peptide fingerprint (MCFP)
based on monomer composition of NRPs. Experiments
with the Norine NRPs database, clearly show the useful-
ness and effectiveness of MCFP for similarity-based
searching and biological activity prediction of nonriboso-
mal peptides.
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